Roscoe JA, Morrow GR, Hickok JT et al (2000) Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in the community. J Pain Symptom Manage 20:113–121

Article  PubMed  CAS  Google Scholar 

Hickok JT, Roscoe JA, Morrow GR et al (2003) Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemesis: a University of Rochester James P. Wilmot Cancer center community clinical oncology program study of 360 cancer patients treated in the community. Cancer 97:2880–2886

Article  PubMed  CAS  Google Scholar 

De Boer-Dennert M, de Wit R, Schmitz PI, Djontono J et al (1997) Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer 76:1055–1061

PubMed  Google Scholar 

Griffin AM, Butow PN, Coates AS et al (1996) On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189–195

PubMed  CAS  Google Scholar 

Osoba D, Zee B, Warr D et al (1997) Effect of postchemotherapy nausea and vomiting on health-related quality of life. Support Care Cancer 5:307–313

Article  PubMed  CAS  Google Scholar 

Rusthoven JJ, Osoba D, Butts CA et al (1998) The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy. Support Care Cancer 6:389–395

Article  PubMed  CAS  Google Scholar 

Bloechl-Daum B, Deuson RR, Mavros P et al (2006) Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol 24:4472–4478

Article  PubMed  CAS  Google Scholar 

Foubert J, Vaessen G (2005) Nausea: the neglected symptom? Eur J Oncol Nurs 9:21–32

Article  PubMed  Google Scholar 

Bergkvist K, Wengstrom Y (2006) Symptom experiences during chemotherapy treatment—with focus on nausea and vomiting. Eur J Oncol Nurs 10:21–29

Article  PubMed  Google Scholar 

Glaus A, Knipping C, Morant R, Böhme C, Lebert B, Glawogger B, Fernandez Ortega P, Hüsler A, Deuson R (2004) Chemotherapy-induced nausea and vomiting in routine practice: a European perspective. Support Care Cancer 12:708–715

Article  PubMed  Google Scholar 

Ihbe-Heffinger A, Ehlken B, Bernard R et al (2004) The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers. Ann Oncol 15:526–536

Article  PubMed  CAS  Google Scholar 

Molassiotis A (2005) Managing nausea and vomiting after cancer treatments: patients still suffer unnecessarily. Eur J Oncol Nurs 9:4–5

Article  PubMed  Google Scholar 

Tonato M, Clark-Snow R, Osoba D et al (2005) Emesis induced by low or minimal emetic risk chemotherapy. Support Care Cancer 13:109–111

Article  PubMed  Google Scholar 

Molassiotis A, Coventry PA, Stricker CT, Clements C, Eaby B, Velders L, Rittenberg C, Gralla RJ (2007) Validation and psychometric properties of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC Antiemesis Tool (MAT). J Pain Symptom Manage 34:148–159

Google Scholar 

Hesketh PJ (1999) Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice. Oncologist 4:191–196

PubMed  CAS  Google Scholar 

Grunberg SM, Osoba D, Hesketh PJ et al (2005) Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity-an update. Support Care Cancer 13:80–84

Article  PubMed  Google Scholar 

Kris MG, Hesketh PJ, Somerfield MR et al (2006) American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol 24:2932–2947

Article  PubMed  CAS  Google Scholar 

Cabana MD, Rand CS, Powe NR et al (1999) Why don’t physicians follow practice guidelines? A framework for improvement. J Am Med Assoc 282:1458–1465

Article  CAS  Google Scholar 

Hesketh PJ, Grunberg SM, Gralla RJ et al (2003) The oral neurokinin-1 antagonist Aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin—the Aprepitant protocol 052 study group. J Clin Oncol 21:4112–4119

Article  PubMed  CAS  Google Scholar 

Poli-Bigelli S, Rodrigues-Pereira J, Carides AD et al (2003) Addition of the neurokinin 1 receptor antagonist Aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer 97:3090–3098

Article  PubMed  CAS  Google Scholar 

Roila F, Donati D, Tamberi S, Margutti G (2002) Delayed emesis: incidence, pattern, prognostic factors and optimal treatment. Support Care Cancer 10:88–95

Article  PubMed  Google Scholar 

Aapro MS, Molassiotis A, Olver I (2005) Anticipatory nausea and vomiting. Support Care Cancer 13:117–121

Article  PubMed  Google Scholar 

Molassiotis A, Yung HP, Yam BMC, Chan FYS, Mok TSK (2002) The effectiveness of progressive muscle relaxation training in managing chemotherapy-induced nausea and vomiting in Chinese breast cancer patients: a randomized controlled trial. Support Care Cancer 10:237–246

Article  PubMed  Google Scholar 

Molassiotis A, Helin AM, Dabbour R, Hummerston S (2007) The effects of P6 acupressure in the prophylaxis of chemotherapy-related nausea and vomiting in breast cancer patients. Complem Ther Med 15:3–12

Article  CAS  Google Scholar 

Morrow GR, Lindke J, Black PM (1991) Predicting the development of anticipatory nausea in cancer patients: prospective evaluation of eight clinical characteristics. J Pain Symptom Manage 6:215–223

Article  PubMed  CAS  Google Scholar 

Gralla RJ, Osoba D, Kris MG, Kirkbride P, Hesketh PJ, Chinnery LW, Clark-Snow R, Gill DP, Groshen S, Grunberg S, Koeller JM, Morrow GR, Perez EA, Silber JH, Pfister DG (1999) Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology. J Clin Oncol 17:2971–2994

PubMed  CAS  Google Scholar 

Fabi A, Barduagni M, Lauro S et al (2003) Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study. Support Care Cancer 11:156–161

PubMed  Google Scholar 

Grunberg SM (2004) Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment—how are we doing? J Support Oncol 2(Suppl 1):1–10

PubMed  Google Scholar